Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-06

Clinical Trial Update: Prevention of Noise-induced Hearing Loss [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating prevention of noise-induced hearing loss has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Noise-induced Hearing Loss | Phase 1, Phase 2 | Status: WITHDRAWN